▶
Driving Development and Supply of a Low-Cost Cholera Vaccine | IVI x IDWeek TV
The oral cholera vaccine (OCV) plays a crucial role in combating cholera—now in its seventh global pandemic. This video dives into the development of the world’s first low-cost OCV, achieved through a collaborative effort between the International Vaccine Institute (IVI), the Bill & Melinda Gates Foundation, and EuBiologics, showcasing the power of public-private partnerships in advancing critical technologies and global health goals. IVI and our partners remain dedicated to not only accelerating safe and effective vaccines but making them accessible to those who need them. With our global network of partners, we are at work to solve some of the world’s most neglected infectious disease challenges. Learn more about our cholera program: https://www.ivi.int/what-we-do/disease-areas/cholera/.
Follow IVI on social media
X: https://twitter.com/IVIHeadquarters
Facebook: https://www.facebook.com/InternationalVaccineInstitute
Instagram: https://www.instagram.com/internationalvaccineainstitute/
LinkedIn: https://www.linkedin.com/company/international-vaccine-institute/
Subscribe to our mailing list: https://bit.ly/subscribe-to-ivi
